Endothelin modulates the cardiovascular effects of clonidine in the rat

Pharmacological Research

Volumn 62, Issue 6, 2010, Pages 489-499

  Lavhale, Manish S ^a   Briyal, Seema ^a   Parikh, Niket ^a   Gulati, Anil ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Adrenergic receptors; BMS 182874; BQ 788; Cardiovascular; Clonidine; Endothelin; IRL 1620; TAK 044

Indexed keywords

5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PRAZOSIN; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; TAK 044;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA CONSTRICTION; ARTICLE; BRAIN; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; VASCULAR RING;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA, ABDOMINAL; BLOOD GAS ANALYSIS; BLOOD PRESSURE; BRAIN; CLONIDINE; ENDOTHELINS; HEART RATE; MALE; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PIPERIDINES; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ENDOTHELIN; VASOCONSTRICTION;

EID: 78049530442     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2010.08.005     Document Type: Article

References (57)

1. Guyenet P.G., Cabot J.B. Inhibition of sympathetic preganglionic neurons by catecholamines and clonidine: mediation by an alpha-adrenergic receptor. J Neurosci 1981, 1:908-917.
2. Kobinger W. Central alpha-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 1978, 81:39-100.
3. U'Prichard D.C., Greenberg D.A., Snyder S.H. Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. Mol Pharmacol 1977, 13:454-473.
4. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411-415.
5. Sakamoto A., Yanagisawa M., Sawamura T., Enoki T., Ohtani T., Sakurai T., Nakao K., Toyo-oka T., Masaki T. Distinct subdomains of human endothelin receptors determine their selectivity to endothelina-selective antagonist and endothelinb-selective agonists. J Biol Chem 1993, 268:8547-8553.
6. Gulati A., Kumar A., Morrison S., Shahani B.T. Effect of centrally administered endothelin agonists on systemic and regional blood circulation in the rat: role of sympathetic nervous system. Neuropeptides 1997, 31:301-309.
7. Gulati A., Rebello S., Kumar A. Role of sympathetic nervous system in cardiovascular effects of centrally administered endothelin-1 in rats. Am J Physiol 1997, 273:H1177-1186.
8. Gulati A. Evidence for antagonistic activity of endothelin for clonidine induced hypotension and bradycardia. Life Sci 1992, 50:153-160.
9. Gulati A., Srimal R.C. Endothelin antagonizes the hypotension and potentiates the hypertension induced by clonidine. Eur J Pharmacol 1993, 230:293-300.
10. Tabuchi Y., Nakamaru M., Rakugi H., Nagano M., Mikami H., Ogihara T. Endothelin inhibits presynaptic adrenergic neurotransmission in rat mesenteric artery. Biochem Biophys Res Commun 1989, 161:803-808.
11. Wiklund N.P., Ohlen A., Cederqvist B. Inhibition of adrenergic neuroeffector transmission by endothelin in the guinea-pig femoral artery. Acta Physiol Scand 1988, 134:311-312.
12. Maggi C.A., Meli A. Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 2: Cardiovascular system. Experientia 1986, 42:292-297.
13. Pacher P., Nagayama T., Mukhopadhyay P., Batkai S., Kass D.A. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 2008, 3:1422-1434.
14. Charu R., Stobdan T., Ram R.B., Khan A.P., Qadar Pasha M.A., Norboo T., Afrin F. Susceptibility to high altitude pulmonary oedema: role of ace and et-1 polymorphisms. Thorax 2006, 61:1011-1012.
15. Radovits T., Zotkina J., Lin L.N., Karck M., Szabo G. Endothelial dysfunction after hypoxia-reoxygenation: do in vitro models work?. Vascul Pharmacol 2009, 51:37-43.
16. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 1951, 193:265-275.
17. Schmitt H. Localization of the hypotensive effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (st 155, catapresan). Eur J Pharmacol 1969, 6:8-12.
18. Gulati A., Hussain G., Srimal R.C. Effect of repeated administration of clonidine on adrenergic, cholinergic (muscarinic), dopaminergic, and serotonergic receptors in brain-regions of rats. Drug Development Res 1991, 22:141-152.
19. Chen H.I., Li H.T., Chen C.C. Physical conditioning decreases norepinephrine-induced vasoconstriction in rabbits. Possible roles of norepinephrine-evoked endothelium-derived relaxing factor. Circulation 1994, 90:970-975.
20. Langer S.Z., Cavero I., Massingham R. Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents. Hypertension 1980, 2:372-382.
21. van Zwieten P.A., Thoolen M.J., Timmermans P.B. The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine. Hypertension 1984, 6:II28-II33.
22. Bousquet P., Schwartz J. Alpha-adrenergic drugs. Pharmacological tools for the study of the central vasomotor control. Biochem Pharmacol 1983, 32:1459-1465.
23. Timmermans P.B., Van Zwieten P.A. Postsynaptic alpha 1- and alpha 2-adrenoceptors in the circulatory system of the pithed rat: Selective stimulation of the alpha 2-type by b-ht 933. Eur J Pharmacol 1980, 63:199-202.
24. Ikeda S., Awane Y., Kusumoto K., Wakimasu M., Watanabe T., Fujino M. A new endothelin receptor antagonist, tak-044, shows long-lasting inhibition of both eta- and etb-mediated blood pressure responses in rats. J Pharmacol Exp Ther 1994, 270:728-733.
25. Stein P.D., Hunt J.T., Floyd D.M., Moreland S., Dickinson K.E., Mitchell C., Liu E.C., Webb M.L., Murugesan N., Dickey J., et al. The discovery of sulfonamide endothelin antagonists and the development of the orally active eta antagonist 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide. J Med Chem 1994, 37:329-331.
26. Leonard M.G., Gulati A. Repeated administration of et(b) receptor agonist, irl-1620, produces tachyphylaxis only to its hypotensive effect. Pharmacol Res 2009, 60:402-410.
27. Rai A., Gulati A. Evidence for the involvement of et(b) receptors in et-1-induced changes in blood flow to the rat breast tumor. Cancer Chemother Pharmacol 2003, 51:21-28.
28. Rajeshkumar N.V., Rai A., Gulati A. Endothelin b receptor agonist, irl 1620, enhances the anti-tumor efficacy of paclitaxel in breast tumor rats. Breast Cancer Res Treat 2005, 94:237-247.
29. Gulati A., Rai A. Endothelin-1-induced vasodilatation in rat breast tumor is mediated through endothelin-b receptors. J Cardiovasc Pharmacol 2004, 44(Suppl 1):S483-S486.
30. Harada N., Himeno A., Shigematsu K., Sumikawa K., Niwa M. Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an eta-etb receptor heterodimer. Cell Mol Neurobiol 2002, 22:207-226.
31. Just A., Olson A.J., Arendshorst W.J. Dual constrictor and dilator actions of et(b) receptors in the rat renal microcirculation: interactions with et(a) receptors. Am J Physiol Renal Physiol 2004, 286:F660-F668.
32. Gregan B., Jurgensen J., Papsdorf G., Furkert J., Schaefer M., Beyermann M., Rosenthal W., Oksche A. Ligand-dependent differences in the internalization of endothelin a and endothelin b receptor heterodimers. J Biol Chem 2004, 279:27679-27687.
33. Gregan B., Schaefer M., Rosenthal W., Oksche A. Fluorescence resonance energy transfer analysis reveals the existence of endothelin-a and endothelin-b receptor homodimers. J Cardiovasc Pharmacol 2004, 44(Suppl 1):S30-S33.
34. Thakali K., Galligan J.J., Fink G.D., Gariepy C.E., Watts S.W. Pharmacological endothelin receptor interaction does not occur in veins from et(b) receptor deficient rats. Vascul Pharmacol 2008, 49:6-13.
35. Claing A., Shbaklo H., Plante M., Bkaily G., D'Orleans-Juste P. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein. Br J Pharmacol 2002, 135:433-443.
36. Lodge N.J., Zhang R., Halaka N.N., Moreland S. Functional role of endothelin eta and etb receptors in venous and arterial smooth muscle. Eur J Pharmacol 1995, 287:279-285.
37. Mickley E.J., Gray G.A., Webb D.J. Activation of endothelin eta receptors masks the constrictor role of endothelin etb receptors in rat isolated small mesenteric arteries. Br J Pharmacol 1997, 120:1376-1382.
38. Perez-Rivera A.A., Fink G.D., Galligan J.J. Vascular reactivity of mesenteric arteries and veins to endothelin-1 in a murine model of high blood pressure. Vascul Pharmacol 2005, 43:1-10.
39. Sauvageau S., Thorin E., Caron A., Dupuis J. Evaluation of endothelin-1-induced pulmonary vasoconstriction following myocardial infarction. Exp Biol Med (Maywood) 2006, 231:840-846.
40. Goddard J., Johnston N.R., Cumming A.D., Webb D.J. Fractional urinary excretion of endothelin-1 is reduced by acute etb receptor blockade. Am J Physiol Renal Physiol 2007, 293:F1433-F1438.
41. Dupuis J., Goresky C.A., Fournier A. Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of etb receptors. J Appl Physiol 1996, 81:1510-1515.
42. Fukuroda T., Fujikawa T., Ozaki S., Ishikawa K., Yano M., Nishikibe M. Clearance of circulating endothelin-1 by etb receptors in rats. Biochem Biophys Res Commun 1994, 199:1461-1465.
43. Salamoussa A., Lau W.A., Pennefather J.N., Ventura S. The contractile effects of endothelins on the smooth muscle of the rat prostate gland. Eur J Pharmacol 2000, 403:139-145.
44. Langenstroer P., Tang R., Shapiro E., Divish B., Opgenorth T., Lepor H. Endothelin-1 in the human prostate: tissue levels, source of production and isometric tension studies. J Urol 1993, 150:495-499.
45. Miyauchi T., Tomobe Y., Shiba R., Ishikawa T., Yanagisawa M., Kimura S., Sugishita Y., Ito I., Goto K., Masaki T. Involvement of endothelin in the regulation of human vascular tonus. Potent vasoconstrictor effect and existence in endothelial cells. Circulation 1990, 81:1874-1880.
46. Bender S.B., Klabunde R.E. Altered role of smooth muscle endothelin receptors in coronary endothelin-1 and alpha1-adrenoceptor-mediated vasoconstriction in type 2 diabetes. Am J Physiol Heart Circ Physiol 2007, 293:H2281-H2288.
47. D'Angelo G., Pollock J.S., Pollock D.M. In vivo evidence for endothelin-1-mediated attenuation of alpha1-adrenergic stimulation. Am J Physiol Heart Circ Physiol 2006, 290:H1251-H1258.
48. Kennedy W.B., Crane L., Gonzalez R.R., George O.K., Edwards L.P. Centrally acting imidazolines stimulate vascular alpha 1a-adrenergic receptors in rat-tail artery. Cell Mol Neurobiol 2006, 26:645-657.
49. Jarajapu Y.P., Hillier C., MacDonald A. The alpha(1a)-adrenoceptor subtype mediates contraction in rat femoral resistance arteries. Eur J Pharmacol 2001, 422:127-135.
50. Fagura M.S., Lydford S.J., Dougall I.G. Pharmacological classification of alpha 1-adrenoceptors mediating contractions of rabbit isolated ear artery: comparison with rat isolated thoracic aorta. Br J Pharmacol 1997, 120:247-258.
51. Souza H.C., Terzini G.C., da Silva V.J., Martins-Pinge M.C., Salgado H.C., Salgado M.C. Increased cardiac sympathetic drive and reduced vagal modulation following endothelin receptor antagonism in healthy conscious rats. Clin Exp Pharmacol Physiol 2008, 35:751-756.
52. Matsumura K., Abe I., Tsuchihashi T., Tominaga M., Kobayashi K., Fujishima M. Central effect of endothelin on neurohormonal responses in conscious rabbits. Hypertension 1991, 17:1192-1196.
53. Liu J.L., Pliquett R.U., Brewer E., Cornish K.G., Shen Y.T., Zucker I.H. Chronic endothelin-1 blockade reduces sympathetic nerve activity in rabbits with heart failure. Am J Physiol Regul Integr Comp Physiol 2001, 280:R1906-R1913.
54. Pai G.S., Lipsitz D.J. Clonidine poisoning. Pediatrics 1976, 58:749-750.
55. Hunyor S.N., Bradstock K., Somerville P.J., Lucas N. Clonidine overdose. Br Med J 1975, 4:23.
56. Abo-Zena R.A., Bobek M.B., Dweik R.A. Hypertensive urgency induced by an interaction of mirtazapine and clonidine. Pharmacotherapy 2000, 20:476-478.
57. Troncoso A.L., Gill T. Hypertensive urgency with clonidine and mirtazepine. Psychosomatics 2004, 45:449-450.